Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Mar 01, 2008 (Vol. 28, No. 5)

ActionBioscience

URL:www.actionbioscience.org
  • Excellent writing
  • Nothing significant
A self-described education resource to promote bioscience literacy, ActionBioscience is a product of the American Institute of Biological Sciences. The site is well along it way to achieving its aim, with seven hyperlinked bioscience challenges – Biodiversity, Environment, Genomics, Biotechnology, Evolution, New Frontiers, and Education. Under each of those headings resides dozens of outstandingly written articles on the subject. I particularly enjoyed (and learned a lot) reading articles on speciation and biodiversity (interview with E.O. Wilson), separating “fundamentalist science” from “science” (by Tim Berra), and looking for life on Mars and beyond, by Abigail Salyers. This is not the kind of site where you come looking for a quick fix of information. Instead, the numerous, well-written articles make for excellent, informative reading. Give yourself an afternoon or an evening to enjoy this one.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »